Ons laatste Nieuws
Bekijk alle nieuwsberichten op farmaactueel.nl
05 feb
Pfizer to Buy Hospira in Deal Valued at About $17 Billion
Pfizer Inc. agreed to buy Hospira Inc., the biggest provider of injectable drugs, in a transaction valued at about $17 billion, beefing up its roster of generic medicine ahead of a potential spinoff.(Bloomberg)
Pfizer Inc. agreed to buy Hospira Inc., the biggest provider of injectable drugs, in a transaction valued at about $17 billion, beefing up its roster of generic medicine ahead of a potential spinoff.(Bloomberg)
Blijf op de hoogte
Wilt u altijd op de hoogte blijven van de laatste veranderingen en nieuws over Farma-actueel? Vraag de nieuwsbrief aan door uw e-mailadres hieronder in te vullen.